Literature DB >> 23975687

Determinants of hospital mortality among patients with sepsis or septic shock receiving appropriate antibiotic treatment.

Colleen McEvoy1, Marin H Kollef.   

Abstract

Septic shock affects 750,000 people annually, and accounts for 10 % of all deaths annually in the US. In recent years, outcomes in patients with septic shock have improved; however, mortality still remains high at 40 - 50 %. The use of early protocolized resuscitation goals have been associated with reduced mortality in septic shock. However, strong evidenced-based recommendations for the continued management of patients with septic shock in the ICU setting are currently lacking. Appropriate antibiotic therapy is the cornerstone of management in septic shock. Inappropriate antibiotic therapy can lead to treatment failures and adverse outcomes, including high risk of mortality. This article outlines other key factors that contribute to outcome in septic shock. It is challenging for physicians to optimize therapy when fixed patient features such as age and underlying comorbidity can negatively influence mortality. However, outcomes can also potentially be affected by physician management decisions including fluid balance, corticosteroid use, glucose control and adherence to protocols including early goal-directed therapy and infection-control measures. Certain pathogen virulence characteristics also adversely affect outcomes. We give an overview of the determinants of outcome in septic shock in the setting of appropriate antibiotic use.

Entities:  

Year:  2013        PMID: 23975687     DOI: 10.1007/s11908-013-0361-1

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  71 in total

1.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

2.  Early changes in organ function predict eventual survival in severe sepsis.

Authors:  Mitchell M Levy; William L Macias; Jean-Louis Vincent; James A Russell; Eliezer Silva; Benjamin Trzaskoma; Mark D Williams
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

3.  Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis*.

Authors:  Dae Won Park; Byung-Chul Chun; Soon-Sun Kwon; Young Kyung Yoon; Won Suk Choi; Jang Wook Sohn; Kyong Ran Peck; Yang Soo Kim; Young Hwa Choi; Jun Yong Choi; Sang Il Kim; Joong Sik Eom; Hyo Youl Kim; Hee Jin Cheong; Young Goo Song; Hee Jung Choi; June Myung Kim; Min Ja Kim
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

4.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

Review 5.  Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis.

Authors:  Paul E Marik; Jean-Charles Preiser
Journal:  Chest       Date:  2009-12-16       Impact factor: 9.410

6.  Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study.

Authors:  Jean-Louis Vincent; Yasser Sakr; Charles Sprung; Svein Harboe; Pierre Damas
Journal:  Anesthesiology       Date:  2008-01       Impact factor: 7.892

7.  EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units.

Authors:  C Brun-Buisson; P Meshaka; P Pinton; B Vallet
Journal:  Intensive Care Med       Date:  2004-03-02       Impact factor: 17.440

8.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

9.  Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients.

Authors:  Joseph A Johnston; Douglas P Wagner; Stephen Timmons; Deborah Welsh; Joel Tsevat; Marta L Render
Journal:  Med Care       Date:  2002-10       Impact factor: 2.983

10.  The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*.

Authors:  Andrew Labelle; Paul Juang; Richard Reichley; Scott Micek; Justin Hoffmann; Alex Hoban; Nicholas Hampton; Marin Kollef
Journal:  Crit Care Med       Date:  2012-07       Impact factor: 7.598

View more
  5 in total

1.  Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.

Authors:  Jevgenia Zilberman-Rudenko; Stéphanie E Reitsma; Cristina Puy; Rachel A Rigg; Stephanie A Smith; Erik I Tucker; Robert Silasi; Alona Merkulova; Keith R McCrae; Coen Maas; Rolf T Urbanus; David Gailani; James H Morrissey; András Gruber; Florea Lupu; Alvin H Schmaier; Owen J T McCarty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

2.  An elevated percentage of reticulated platelet is associated with increased mortality in septic shock patients.

Authors:  Qin Wu; Jianan Ren; Dong Hu; Pengjun Jiang; Guanwei Li; Nadeem Anjum; Gefei Wang; Guosheng Gu; Jun Chen; Xiuwen Wu; Song Liu; Yuan Li; Yunzhao Zhao; Jieshou Li
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

3.  Septic shock and the use of norepinephrine in an intermediate care unit: Mortality and adverse events.

Authors:  Mikael Hallengren; Per Åstrand; Staffan Eksborg; Hans Barle; Claes Frostell
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

4.  Cohort profile: Greifswald approach to individualized medicine (GANI_MED).

Authors:  Hans J Grabe; Heinrich Assel; Thomas Bahls; Marcus Dörr; Karlhans Endlich; Nicole Endlich; Pia Erdmann; Ralf Ewert; Stephan B Felix; Beate Fiene; Tobias Fischer; Steffen Flessa; Nele Friedrich; Mariacarla Gadebusch-Bondio; Manuela Gesell Salazar; Elke Hammer; Robin Haring; Christoph Havemann; Michael Hecker; Wolfgang Hoffmann; Birte Holtfreter; Tim Kacprowski; Kathleen Klein; Thomas Kocher; Holger Kock; Janina Krafczyk; Jana Kuhn; Martin Langanke; Uwe Lendeckel; Markus M Lerch; Wolfgang Lieb; Roberto Lorbeer; Julia Mayerle; Konrad Meissner; Henriette Meyer zu Schwabedissen; Matthias Nauck; Konrad Ott; Wolfgang Rathmann; Rainer Rettig; Claudia Richardt; Karen Saljé; Ulf Schminke; Andrea Schulz; Matthias Schwab; Werner Siegmund; Sylvia Stracke; Karsten Suhre; Marius Ueffing; Saskia Ungerer; Uwe Völker; Henry Völzke; Henri Wallaschofski; Vivian Werner; Marek T Zygmunt; Heyo K Kroemer
Journal:  J Transl Med       Date:  2014-05-23       Impact factor: 5.531

5.  Inflammation and cardiac dysfunction during sepsis, muscular dystrophy, and myocarditis.

Authors:  Ying Li; Shuping Ge; Yizhi Peng; Xiongwen Chen
Journal:  Burns Trauma       Date:  2013-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.